Abu Dhabi Investment Authority 13D/13G Filings for Eikon Therapeutics, Inc. Common Stock (EIKN)

Abu Dhabi Investment Authority 13D and 13G filings for Eikon Therapeutics, Inc. Common Stock:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2026-02-18
4:16 pm
Purchase
2026-02-0413GEIKON THERAPEUTICS INC
EIKN
Abu Dhabi Investment Authority2,816,714
5.200%
2,816,714increase
(New Position)
Filing